Therapeutic response to interferon-beta in multiple sclerosis:: relating MxA transcription to neutralising antibody levels

被引:0
|
作者
Hoffmann, L. A. [1 ]
Krurnbholz, M. [1 ]
Faber, H. [1 ]
Starck, M. [1 ]
Pollmann, W. [1 ]
Meinl, E. [1 ]
机构
[1] Inst Clin Neuroimmunol, Munich, Germany
来源
MULTIPLE SCLEROSIS | 2006年 / 12卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S207 / S207
页数:1
相关论文
共 50 条
  • [32] Prescribing Recommendations For Interferon-Beta In Multiple Sclerosis
    Bianca Weinstock-Guttman
    Richard A. Rudick
    CNS Drugs, 1997, 8 : 102 - 112
  • [33] Prescribing recommendations for interferon-beta in multiple sclerosis
    WeinstockGuttman, B
    Rudick, RA
    CNS DRUGS, 1997, 8 (02) : 102 - 112
  • [34] Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability
    Giedraitiene, Natasa
    Kaubrys, Gintaras
    Kizlaitiene, Rasa
    Bagdonate, Loreta
    Griskevicius, Laimonas
    Valceckiene, Vilma
    Stoskus, Mindaugas
    MEDICAL SCIENCE MONITOR, 2015, 21 : 1512 - 1519
  • [35] Use of MxA mRNA and neutralising antibodies detection as predictive factors of interferon beta clinical efficacy in multiple sclerosis patients
    Malucchi, S.
    Sala, A.
    Capobianco, M.
    di Sapio, A.
    Marnetto, F.
    Caldano, M.
    Valentino, P.
    Gilli, F.
    Bertolotto, A.
    MULTIPLE SCLEROSIS, 2006, 12 : S206 - S206
  • [36] Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients
    Matas, Elisabet
    Bau, Laura
    Martinez-Iniesta, Maria
    Romero-Pinel, Lucia
    Alba Mane, M.
    Cobo-Calvo, Alvaro
    Martinez-Yelamos, Sergio
    PLOS ONE, 2014, 9 (11):
  • [37] The measurement of antibodies binding to interferon-beta in Iranian multiple sclerosis patients treated with interferon-beta
    Jangouk, P
    Hooshmand, E
    Vaezeafshar, R
    Lotfi, J
    Amirzargar, A
    Nikbin, B
    JOURNAL OF NEUROLOGY, 2004, 251 : 64 - 64
  • [38] Immune response to immunotherapy:: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis
    Hemmer, B
    Stüve, O
    Kieseier, B
    Schellekens, H
    Hartung, HP
    LANCET NEUROLOGY, 2005, 4 (07): : 403 - 412
  • [39] Correlation of neutralising antibody status with side effects of interferon beta therapy in patients with multiple sclerosis
    Cossoy, M. B.
    Rush, C.
    Campbell, T. L.
    Kremenchutzky, M.
    Bhan, V.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 : S61 - S61
  • [40] Neutralising antibodies to interferon beta during the treatment of multiple sclerosis
    Giovannoni, G
    Munschauer, FE
    Deisenhammer, F
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (05): : 465 - 469